$30.89
0.11 (-0.35%)
Last updated: Jul 15, 2026 06:56
Fundamentals Overview
Beam Therapeutics Inc. is in the middle of its 52-week range with premium valuation, trading relatively flat today.
Valuation premium
Risk (Beta)
2.18 — higher vol
BullzEye Analysis
Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
Sentiment improving (5 upgrades)
Pressures (Sell):
3M vs S&P 500: -7.2% · Beta 2.18 (elevated)
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: C-. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 15, Equal Weight: 2, Outperform: 4, Overweight: 4, Sector Outperform: 1, Sector Perform: 4.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $-35.63; current price is $30.89. That’s a -215.3% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | N/A |
| PEG (TTM) | N/A |
| P/B (TTM) | 2.74 |
| P/S (TTM) | 19.38 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 16.99 |
| Quick Ratio (TTM) | 16.99 |
| Cash Ratio (TTM) | 3.87 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | -39.66% |
| Gross margin (TTM) | -39.17% |
| Operating margin (TTM) | -2.27% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for BEAM.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| B of A Securities | maintain | Buy | Buy | 2026-07-08 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2026-07-07 |
| Bernstein | maintain | Outperform | Outperform | 2026-05-13 |
| Citigroup | maintain | Buy | Buy | 2026-03-26 |
| RBC Capital | maintain | Sector Perform | Sector Perform | 2026-02-25 |
| Wedbush | maintain | Outperform | Outperform | 2026-02-25 |
| Bernstein | maintain | Outperform | Outperform | 2026-01-21 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2025-10-10 |
| JP Morgan | maintain | Overweight | Overweight | 2025-10-09 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2025-09-15 |
| Barclays | maintain | Equal Weight | Equal Weight | 2025-08-06 |
| Wells Fargo | maintain | Overweight | Overweight | 2025-05-07 |
| Barclays | maintain | Equal Weight | Equal Weight | 2025-05-07 |
| Guggenheim | maintain | Buy | Buy | 2025-05-07 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2025-04-07 |
| B of A Securities | upgrade | Neutral | Buy | 2025-03-28 |
| Cantor Fitzgerald | maintain | Overweight | Overweight | 2025-03-12 |
| Scotiabank | upgrade | Sector Perform | Sector Outperform | 2025-03-10 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2025-03-10 |
| Jones Trading | upgrade | Hold | Buy | 2025-03-10 |
| Scotiabank | maintain | Sector Perform | Sector Perform | 2025-03-03 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2025-02-28 |
| Guggenheim | maintain | Buy | Buy | 2025-02-27 |
| RBC Capital | maintain | Sector Perform | Sector Perform | 2025-02-26 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2025-02-03 |
| Cantor Fitzgerald | upgrade | Neutral | Overweight | 2025-01-29 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2024-12-09 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2024-11-07 |
| RBC Capital | maintain | Sector Perform | Sector Perform | 2024-11-06 |
| Leerink Partners | upgrade | Market Perform | Outperform | 2024-11-06 |